MARKET WIRE NEWS

ImmuCell Corporation (ICCC) Q4 2024 Earnings Call Transcript

Source: SeekingAlpha

2025-02-26 11:44:02 ET

ImmuCell Corporation (ICCC)

Q4 2024 Earnings Conference Call

February 26, 2025 9:00 AM ET

Company Participants

Joe Diaz - Managing Partner, Lytham Partners, LLC

Michael Brigham - President and Chief Executive Officer

Conference Call Participants

George Melas-Kyriazi - MKH Management

Presentation

Operator

Good morning, and welcome to ImmuCell Corporation Reports its Fourth Quarter and Year Ended December 31, 2024, Unaudited Financial Results Conference Call. All participants will be in listen-only mode. After today’s presentation, there will be an opportunity to ask questions. Please note, this event is being recorded.

I would now like to turn the conference over to Joe Diaz of Lytham Partners. Please go ahead....

Read the full article on Seeking Alpha

For further details see:

ImmuCell Corporation (ICCC) Q4 2024 Earnings Call Transcript
ImmuCell Corporation

NASDAQ: ICCC

ICCC Trading

-3.93% G/L:

$6.35 Last:

15,632 Volume:

$6.61 Open:

mwn-ir Ad 300

ICCC Latest News

ICCC Stock Data

$60,757,363
6,377,325
3.65%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Portland

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App